Unlocking Our Treasures Enhancing Access to Tissue for Genomics Research Henry Chueh Massachusetts General Hospital Harvard Medical School Internet2 Member.

Slides:



Advertisements
Similar presentations
Medical Image Resource Center. What is MIRC? Medical Image Resource Center Makes it easier to locate and share electronic medical images and related information.
Advertisements

Regulation of Consumer Tests in California AAAS Meeting June 1-2, 2009 Beatrice OKeefe Acting Chief, Laboratory Field Services California Department of.
The Diagnostic Laboratory ……the ideal system……. Molecular Genetics Diagnostic Laboratory Exciting area of medical pathology Need to continually up-date.
1 Phenotype Prediction by Integrative Network Analysis of SNP and Gene Expression Microarrays Hsun-Hsien Chang 1, Michael McGeachie 1,2 1 Children’s Hospital.
One more type of tissue to discuss A type of tissue that none of us want in our body.
Presentation to Educational Policy Committee Department of Biology Revised March, 2013 Biology Department: Position Requests.
Michael Birrer, PI, Director, Gynecologic Medical Oncology, MGH Lari Wenzel, Co-PI, Prof. of Medicine, University of California, Irvine
Gene regulation in cancer 11/14/07. Overview The hallmark of cancer is uncontrolled cell proliferation. Oncogenes code for proteins that help to regulate.
The Age of Personalized Medicine Moves Research to the Bedside The UPMC Strategic Framework Steven D. Shapiro M.D. Executive Vice President, UPMC Chief.
Rapid Deployment and Adoption of Health Information Technology for Real Time Biosurveillance Primary support: NCI, NLM, CDC, and the DF/HCC.
Tissue Banking Marilyn Mason, Ph.D. January 14, 2009.
Overview of Biomedical Informatics Rakesh Nagarajan.
Dr Shafiq Khan Lab Transforming Growth Factor beta (TGF-  ) signaling How TGF-  promotes tumor progression The role of the different TGF-  isoforms.
Introduction to Genomics, Bioinformatics & Proteomics Brian Rybarczyk, PhD PMABS Department of Biology University of North Carolina Chapel Hill.
BTRIS: The NIH Biomedical Translational Research Information System James J. Cimino Chief, Laboratory for Informatics Development NIH Clinical Center.
Harvard Catalyst: How Can It Help Your Research? Steven D. Freedman MD PhD Professor of Medicine, HMS Associate Dean for Clinical and Translational Research,
BTRIS: The NIH Biomedical Translational Research Information System James J. Cimino Chief, Laboratory for Informatics Development NIH Clinical Center.
Jennie Bell CMGS/ACC Spring meeting 14 th April 2010.
The NIH Roadmap for Medical Research
Welcome to the Fall 2010 TBPT Meeting Dr. Paul Klotman President and CEO Baylor College of Medicine November 3, 2010.
Software Integration with PopMedNet PopMedNet Users Group Meeting Boston, MA July 27, 2015 Jeffrey S. Brown, PhD Associate Professor Department of Population.
2nd Quebec Conference on Therapeutic Resistance in Cancer Bienvenue !!!!!
Introductory Overview
Overview of the Harvard Catalyst Imaging program Randy Gollub,MD,PhD; Valerie Humblet,PhD April 28, 2009.
Leveraging the Electronic Health Record for Clinical Research John P. Glaser, PhD Vice President and CIO Partners HealthCare July 21, 2008.
Shared Health Research Information Network Andrew McMurry Sr. Research Software Developer Harvard Medical School Center for BioMedical Informatics Children's.
Information Resources and Technology We facilitate excellence in education, biomedical and clinical research, and patient care through the application.
Human Research Protection Programs 1a: How to Navigate Human Subject Protection Regulations Sponsored by the American Society for Investigative Pathology.
Tumor Profile Discovery and Tumor Bank Management with DORA Adrian Driga 1, Russ Greiner 2, Kathryn Graham 1, 4, Sambasivarao Damaraju 1, 4, David Wishart.
Shared Health Research Information Network Andrew McMurry, MS SHRINE Architect Harvard Medical School Center for BioMedical Informatics Children’s Hospital.
Linking Harvard for Clinical and Translational Science Powered by SPIN: Shared Pathology Informatics Network Primary support: NCI, NLM, and the DF/HCC.
PrognoChip Mediator, FORTH-ICS 1 Integrating Clinical and Genomic Information through the PrognoChip Mediator Implemented by Manos Kalaitzakis, Dimitris.
The analyses upon which this publication is based were performed under Contract Number HHSM C sponsored by the Center for Medicare and Medicaid.
Indiana Institute For Personalized Medicine David A Flockhart MD, PhD Professor of Medicine, Genetics and Pharmacology Indiana University.
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) in Non-Small Cell Lung Cancer (NSCLC) Victor.
Page 1 Informatics Pilot Project EDRN Knowledge System Working Group San Antonio, Texas January 21, 2001 Steve Hughes Thuy Tran Dan Crichton Jet Propulsion.
The NIH Roadmap and the Human Microbiome Project Francis S. Collins, M.D., Ph.D. National Human Genome Research Institute April 22, 2007.
1 A National Virtual Specimen Database for Early Cancer Detection June 26, 2003 Daniel Crichton NASA Jet Propulsion Laboratory Sean Kelly NASA Jet Propulsion.
Surgical Planning Laboratory Brigham and Women’s Hospital Boston, Massachusetts USA a teaching affiliate of Harvard Medical School Overview Ron Kikinis,
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
Development of Harvard Catalyst Imaging Consultation Service Simon K. Warfield, Ph.D. Valerie Humblet, Ph.D. on behalf of the CTSC Imaging Committee
Facilitate Scientific Data Sharing by Sharing Informatics Tools and Standards Belinda Seto and James Luo National Institute of Biomedical Imaging and Bioengineering.
© 2005 Prentice Hall Inc. / A Pearson Education Company / Upper Saddle River, New Jersey Lung Cancer and Gefitinib  Lung cancer statistics in the.
GBIF Data Access and Database Interoperability 2003 Work Programme Overview Donald Hobern, GBIF Programme Officer for Data Access and Database Interoperability.
BBN Technologies Copyright 2009 Slide 1 The S*QL Plugin for Cytoscape Visual Analytics on the Web of Linked Data Rusty (Robert J.) Bobrow Jeff Berliner,
The Importance of Tissue Banking and Tissue Research Mark E. Sobel, M.D., Ph.D. Executive Officer, American Society for Investigative Pathology
GeWorkbench Overview Support Team Molecular Analysis Tools Knowledge Center Columbia University and The Broad Institute of MIT and Harvard.
The Basis of Genetics. The Cell Cycle Cell Signaling.
FACULTY of ARTS and SCIENCES HARVARD BUSINESS SCHOOL GRADUATE SCHOOL OF DESIGN HARVARD DIVINITY SCHOOL Center for the Study of World Religions Summer.
NA-MIC National Alliance for Medical Image Computing NAMIC Software Development Workshop December 9-10, 2004 Surgical Planning Lab, Brigham.
Genomic Medicine Rebecca Tay Oncology Registrar. What is Genomic Medicine? personalised, precision or stratified medicine.
NIHR Southampton Biomedical Research Centre The Southampton Biomedical Research Centre is funded by the National Institute for Health Research (NIHR) and.
Genomic Medicine Grid Juan Pedro Sánchez Merino Instituto de Salud Carlos III
CTTI PROJECT Emory University, Quality Assurance and Review Center (QARC) and Washington University in St. Louis.
De-identification using Harvard Scrubber Umit Topaloglu, Ph.D.
Enhancements to Galaxy for delivering on NIH Commons
Samsung Genome Institute Samsung Medical Center
Semantic Web - caBIG Abstract: 21st century biomedical research is driven by massive amounts of data: automated technologies generate hundreds of.
Scientific Reproducibility using the Provenance for Healthcare and Clinical Research Framework Satya S. Sahoo Collaborators/Co-Authors: Joshua Valdez,
Stony Brook University The Process for Joining TIES
Figure 1. Resistance mechanism against first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). (A) Mutations in the EGFR.
Development of Harvard Catalyst Imaging Consultation Service
Harry Hochheiser Assistant Professor
Patient Case 1 Patient Case 1: PET/CT Scan.
Meta-analysis of randomised phase III clinical trials comparing EGFR tyrosine kinase inhibitor (TKI) shows that male patients with non-small cell lung.
Clinical courses of patients.
Daniel Haber MD PhD Massachusetts General Hospital Cancer Center
Fig. 1 Molecular imaging of EGFR-activating mutation status for stratification of patients. Molecular imaging of EGFR-activating mutation status for stratification.
One more type of tissue to discuss
Patterns of clinical relapse and algorithm for the therapeutic strategy when AR to EGFR TKI occurs in patients with EGFR-mutant NSCLC. *After discussion.
Presentation transcript:

Unlocking Our Treasures Enhancing Access to Tissue for Genomics Research Henry Chueh Massachusetts General Hospital Harvard Medical School Internet2 Member Meeting Austin, Texas September 30, 2004

“ Be careful of reading health books. You may die of a misprint.” Mark Twain

Genetic alphabet AT GC

Mutations Image credit: U.S. Department of Energy Human Genome Program,

Molecular foundation of disease Image credit: U.S. Department of Energy Joint Genome Institute

Epithelial Growth Factor Receptor Angiogenesis Metastasis EGFR Tyrosine Kinase Receptor Invasion Proliferation K K EGFR-TK Inhibitor Cell membrane Image credit: Modified from Astra-Zeneca educational materials

Lynch, T. J. et al. N Engl J Med 2004;350: Clustering of Mutations in the EGFR Gene at Critical Sites within the ATP-Binding Pocket

Genomics research  Clinical research in the genomics era requires, at a minimum:  Access to diseased and healthy tissue  Clinical information associated with the tissue (demographics, outcomes, etc)

Shared Pathology Information Network

SPIN Collaborators  National Cancer Institute (NCI)  Children’s Hospital  Massachusetts General Hospital  Brigham and Women’s Hospital  Dana-Farber Cancer Institute  Beth Israel Hospital  UCLA Medical Center  Regenstrief Institute  Univ. of Pittsburgh Medical Center

SPIN Themes  Think “framework”  Specifications clear enough to develop products independently  Local control  Network planning

SPIN: p2p Model Assumptions  No ongoing aggregation of data, no central repository to govern  Provision of data into a SPIN node from systems internal to the institution is managed locally with SPIN tools  Any information search by any SPIN Query Tool is HIPAA Privacy Rule compliant

SPIN Network Today MGHUCLA HMS CH BI BWH UPMC HMS Tissue Banks (other) OliveViewCedars RI SPIN VSL Running type A SPIN node software Running type B SPIN software Link established Link planned VA

SPIN: Key Activities  Join: Become a member of the network  Host: Provision clinical, specimen data  Search: Locate specimens  Acquire: Obtain specimens

SPIN Host / Search: Data Flow SPIN node De-identified Limited Data Set Institutional Firewall SPIN Query SPIN Response Anonymous or De-identified Data Set InternetIntranet SPIN ProtocolsSPIN Node Software Source Systems Identified Data SPIN Loading Tools Source Systems Clinical Systems Codebook Internal Threshold

Clinical reports to coded annotations … Right colon Chronic colitis Active Mild …

SPIN Query Propagation and Response MGHUCLA BI BWH Query Server SPIN CH SPIN XML request Compose query using a Web browser SPIN request propagates SPIN peer responses return directly to originating SuperNode UPMC RI Cedars SPIN (aggregate) XML Response

Clinical Research Scenarios  ? Rare subset of non-small cell lung cancer (NSCLC) shares common mutation that would make it more susceptible to certain novel therapeutics  ? Infection with herpes zoster (chickenpox) virus enhances mutagenicity in lung cancer

SPIN Open Architecture  Accommodates alternative node and query server implementations  Will accommodate additional data models and schema:  Clinical data (symptoms, outcomes, etc)  Clinical imaging data (MRI, CT scans, etc)  Molecular biology data (microarray data, etc)  Pathology imaging

What’s ahead?  Bringing phenotypes in juxtaposition with genotypic information  NIH roadmap initiatives to include integrated biomedical computing  In silico experiments and analysis

Acknowledgements  Jules Berman (NCI)  Isaac Kohane  Clem McDonald  Jonathan Braun  Michael Becich  Ulysses Balis  David Berkowicz  David Korn (AAMC)  Elias Zerhouni (NIH)

Image credit: U.S. Department of Energy Human Genome Program,